Michael Greene, DO
Pain Medicine · Middleburg, FLNPI 1811215254
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 56 manufacturers reported payments, led by Medtronic at 32.1% of the total. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 695 payments — averaging $104.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$23K
- Biodelivery Sciences International, Inc.$21K
- Vertos Medical, Inc.$12K
- Spinal Simplicity, LLC$4K
- Vertiflex, Inc.$2K
- Boston Scientific$2K
- plus $10K from 50 others
What the payments were for
- Consulting fees$6,6689%
- Speaking & faculty fees$34,43347%
- Travel & lodging$11,99416%
- Food & beverage$19,81027%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BELBUCA$20,478
- INTELLIS ADAPTIVESTIM$16,597
- mild Device Kit$12,675
- Symproic$9,650
- HA MINUTEMAN G3-R$2,890
- Superion ISS$1,618
- INTELLIS$1,019
- INCEPTIV$732
- SPRINT PNS System$417
- PAINTEQ$355
- PROCLAIM$333
- Nalu Neurostimulation System$277
- Intracept$258
- SUPERION$210
- GENERAL PAIN MANAGEMENT$127
- VRAYLAR$125
- UNID_PASS$100
How this compares
$72,940 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 129 | $119,807 |
| Xtampza ErOxycodone Myristate | 71 | $35,955 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,010 | $34,542 |
| Buprenorphine | 145 | $31,588 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,118 | $27,838 |
| LyricaPregabalin | 20 | $15,425 |
| NucyntaTapentadol Hcl | 11 | $14,988 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 72 | $8,896 |
| Pregabalin | 332 | $6,309 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $5,923 |
| Naloxone Hcl | 95 | $5,517 |
| Hysingla ErHydrocodone Bitartrate | 11 | $5,203 |
| OxycontinOxycodone Hcl | 11 | $4,597 |
| Oxycodone Hcl | 342 | $4,593 |
| Tramadol Hcl ErTramadol Hcl | 62 | $3,819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $1,031 | $170,750211 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate | $35 | $41,867268 claims |
| PfizerLyrica | $51 | $15,42520 claims |
| Indivior Inc.Suboxone | $25 | $5,92311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Middleburg
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Nicholas BremerFernandina Beach$66K
- Melanie RosenblattBoca Raton$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.